Early research (Phase 1)Study completedNCT00073944What this trial is testingBCX-1777 in Treating Patients With Refractory CancerWho this might be right forCancer BioCryst Pharmaceuticals
Not applicableStudy completedNCT01135849What this trial is testingB-Receptor Signaling in CardiomyopathyWho this might be right forCarcinomasAmyloidosisAnal Cancer+35 more Daniel Bernstein 99
Early research (Phase 1)Study completedNCT04242199What this trial is testingSafety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid TumorsWho this might be right forAdvanced Solid TumorMSI-H/dMMR TumorsCutaneous Squamous Cell Carcinoma+9 more Incyte Corporation 182
Testing effectiveness (Phase 2)Study completedNCT04068896What this trial is testingStudy of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination TherapyWho this might be right forPancreatic CancerMetastatic Castration-resistant Prostate CancerBladder Cancer+8 more NGM Biopharmaceuticals, Inc 89
Testing effectiveness (Phase 2)Study completedNCT05708950What this trial is testingA Clinical Trial of KVA12123 [TBS-2025] Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)Who this might be right forCancerSolid TumorMelanoma+14 more Kineta Inc. 40
Not applicableLooking for participantsNCT03452774What this trial is testingSYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryWho this might be right forCancer, MetastaticCancerCancer of Pancreas+40 more Massive Bio, Inc. 50,000
Not applicableStudy completedNCT00477919What this trial is testingE-MOSAIC Electronic Tool to Monitor SymptomsWho this might be right forCancer Swiss Cancer Institute 264
Testing effectiveness (Phase 2)Ended earlyNCT04032704What this trial is testingLadiratuzumab Vedotin in Advanced Solid TumorsWho this might be right forSmall Cell Lung CancerNon-small Cell Lung Cancer, SquamousNon-small Cell Lung Cancer, Non-squamous+6 more Seagen Inc. 205
Not applicableStudy completedNCT05461430What this trial is testingMass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)Who this might be right forPleural Effusion, MalignantAscites, MalignantCarcinoma+29 more Travera Inc 72
Early research (Phase 1)Active Not RecruitingNCT05215574What this trial is testingStudy of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid TumorsWho this might be right forPancreatic CancerBreast CancerGastric Cancer+13 more NGM Biopharmaceuticals, Inc 130
Testing effectiveness (Phase 2)Not Yet RecruitingNCT04889742What this trial is testingHyperthermia Enhanced Re-irradiation of Loco-regional Recurrent TumorsWho this might be right forRecurrent CancerProstate CancerCervical Cancer+7 more Charite University, Berlin, Germany 110
Testing effectiveness (Phase 2)Study completedNCT00948961What this trial is testingCDX-1401 in Patients With Malignancies Known to Express NY-ESO-1Who this might be right forAdvanced Malignancies Celldex Therapeutics 70
Early research (Phase 1)UnknownNCT03634982What this trial is testingDose Escalation of RMC-4630 Monotherapy in Relapsed/Refractory Solid TumorsWho this might be right forSolid Tumors Revolution Medicines, Inc. 133
Testing effectiveness (Phase 2)Active Not RecruitingNCT04802876What this trial is testingEfficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients with PD1-high MRNA Expressing TumorsWho this might be right forMSI-H Colorectal CancerMelanomaAnal Carcinoma+28 more SOLTI Breast Cancer Research Group 184
Early research (Phase 1)Study completedNCT00002854What this trial is testingHigh-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced CancerWho this might be right forCancer City of Hope Medical Center 33
Large-scale testing (Phase 3)Active Not RecruitingNCT05078047What this trial is testingStudy Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IOWho this might be right forLung Cancer MetastaticRenal Cell CarcinomaHead and Neck Cancer+12 more UNICANCER 646
Early research (Phase 1)Ended earlyNCT06336148What this trial is testingA Phase 1a/1b Study of ACTM-838 in Patients With Advanced Solid TumorsWho this might be right forSolid Tumor Actym Therapeutics, Inc. 10
Early research (Phase 1)Ended earlyNCT03621982What this trial is testingStudy of ADCT-301 in Patients With Selected Advanced Solid TumorsWho this might be right forHead and Neck Cancer Squamous Cell CarcinomaNon-small Cell Lung CancerGastric Cancer+9 more ADC Therapeutics S.A. 78
Testing effectiveness (Phase 2)UnknownNCT00553683What this trial is testingCyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver CancerWho this might be right forBreast CancerColorectal CancerGastric Cancer+5 more Rutgers, The State University of New Jersey 50
Early research (Phase 1)Study completedNCT00020579What this trial is testingMS-275 in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forCancer National Institutes of Health Clinical Center (CC) 75